Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us

Progress in Biochemistry and Biotechnology

Aim & scope

The Progress in Biochemistry and Biotechnology series is a new venture that aims to provide a comprehensive suite of reference books on developing areas in biochemistry and biotechnology. Chapters written by experts worldwide will introduce practical aspects and best methods, will explain the fundamental biochemistry knowledge, and will provide forward-looking perspectives. Ultimately, the series aims to aid postgraduate students and researchers apply biochemical and biotechnological tools and understand current challenges in the field.

The books will provide a valuable reference for scientists working outside their own area of current expertise or looking to engage in biochemistry. Coverage will include topics such as clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease, biochemical physiology, primarily bioenergetics/energy metabolism, cell biology, cellular stress responses, enzymology, intermediary metabolism, macromolecular structure and function, gene regulation, evolutionary genetics. Most volumes will focus on biochemical or molecular analyses that have clear ramifications for physiological processes.

Progress in Biochemistry and Biotechnology

Audience

Academicians, researchers and (post) graduate students engaged in these major research streams of biochemistry like science, technology and medicine and other stakeholders such as policy makers, industrial leaders, professionals.